Autologous Gene Therapy for Hemoglobinopathies: From Bench to Patient’s Bedside

The authors review the mechanisms of action of these various gene addition and gene editing approaches and describe the status of clinical trials designed to evaluate the potentially for these approaches to provide one-time functional cures to patients with transfusion-dependent β-thalassemia and sickle cell disease.